Recruiting

Remote Monitoring

Sponsor:

University of Michigan Rogel Cancer Center

Code:

NCT07912034

Conditions

Bladder Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Best Practice

Communication Intervention

Interview

Smartphone Application-based Intervention

Smartphone Application-based Intervention

Study Details

Brief summary:

This clinical trial tests the feasibility of an electronic health record (EHR) integrated remote patient monitoring intervention to reduce readmission for patients with bladder cancer undergoing cystectomy. Cystectomy is the preferred treatment for locally advanced bladder cancer and involves removal of the bladder, prostate or uterus and part of vagina, and pelvic lymph nodes along with reconstruction of the urinary tract using a segment of bowel. Hospital readmission rates following cystectomy exceed 25% and are among the highest of any surgery. A significant barrier to identifying complications early arises from our inability to monitor patients once they are discharged from the hospital. The EHR integrated remove patient monitoring intervention helps with monitoring of symptoms after a patient's discharge from a cystectomy procedure and provides a direct line of communication between patients and their care team when concerning symptoms arise. This may reduce readmission rate for patients with bladder cancer undergoing cystectomy.

Conditions

Bladder Carcinoma

Study ID

NCT07912034

Start date

Nov 5, 2026

Status verified date

Nov, 2026

Completion date

Jun 1, 2028

Anticipated

Primary completion date

Jun 1, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Adults age 18 and older
  • English speaking
  • Patient currently inpatient at the University of Michigan (Michigan Medicine) who has undergone a radical cystectomy with reconstruction for bladder cancer
  • Personal access or access via a caregiver to a compatible device where notifications from the Michigan Medicine MyUofMHealth account can be enabled

Study Design

Enrollment

50 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Arm I (EHR integrated remote monitoring app)

Patients receive access to the MyUofMHealth App and, starting at discharge, receive notifications, up to 3 times per day with frequency decreasing to daily, then less frequently over time, prompting them to complete medication and pain assessments, record food and fluid intake and exercise and triage/symptom tracking, and provide a direct line of communication to their care team if concerning symptoms arise, up to day 35 post discharge.

experimental: Arm II (Standard care)

Patients receive access to the MyUofMHealth App and undergo standard post-operative care.

Interventions

Best Practice

Undergo standard post-operative care

Communication Intervention

Communicate with care team

Interview

Ancillary studies

Smartphone Application-based Intervention

Receive access to the MyUofMHealth App

Smartphone Application-based Intervention

Receive notifications

Supportive Care

Complete assessments

Survey Administration

Ancillary studies

Primary outcome measure

  • Trial randomization meeting goal of 50 patients (feasibility) [ Time Frame: Up to 6 months ]

Central Contacts and Locations

Locations

University of Michigan Rogel Cancer Center

Recruiting

Ann Arbor, Michigan, United States, 48109

Contacts

Principal Investigator:

Tudor Borza

More Information

Sponsor

University of Michigan Rogel Cancer Center

Last update posted

Nov 18, 2026

Last verified

Nov, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by University of Michigan Rogel Cancer Center on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.